contraindications for glp-1 agonists Consensus Recommendations on RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Table 5 from Glucagon-Like Peptide-1
Description
How soon can treatment begin
( / mice were studied
Fedak, K
Seo H, Park SJ, Song M
A systematic review found that GLP-1 receptor agonists significantly reduced albuminuria, a marker of kidney damage, and slowed the decline in kidney function, particularly in patients with early-stage renal disease
This finding makes sense because the magnitude of weight loss directly correlates with reduced mechanical stress on weight-bearing joints
